Evidence map›Paper›PMID 41566810›Full record

ArticleProteomics2026

Identifying Subcellular Structure Components in Escherichia Coli by Crosslinking and SEC-MS.

Rachel A Victor, Austin Lipinski, Paul R Langlais, Jacob C Schwartz

Abstract read
In one paragraph

Article in Proteomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel A VictorDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Austin LipinskiDepartment of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Paul R LanglaisDepartment of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Jacob C SchwartzDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, Arizona, USA.

Funding

University of Arizona's Initiatives to Maximize Student DiversityR25GM062584 · NIGMS · UNIVERSITY OF ARIZONA · PI TAX, FRANS E · 2001 to 2017
$7.2M
American Cancer Society RSG-18-237-01-DMCNIGMS NIH HHS R25 GM062584NIH HHS CA238499NIH HHS CA259570Sloan Foundation Higher Education Program G-2017-7327
6 · The paper itself

Abstract

Cells are comprised of a broad spectrum of structures that compartmentalize biochemical and signaling mechanisms. These structures can be comprised of many biomolecules, but especially lipids, proteins, and nucleic acids. Techniques are limited to quantify or discover new subcellular structures. We explored whether a proteomics approach using chemical crosslinking followed by size-exclusion chromatography and mass spectrometry (SEC-MS) of whole cell lysates can address this challenge. Formaldehyde crosslinking was used to preserve the weak molecular interactions responsible for many protein and nucleic acid assemblies. In this study, we perform the first formaldehyde crosslinking-assisted SEC-MS in a bacterial system. We demonstrate that when expressed ectopically in E. coli, large structures of a known assembly protein, FUS, can be detected through SEC-MS. We then show that E. coli proteins are enriched in particles of large or medium size due to formaldehyde crosslinking, which is the first analysis by formaldehyde and SEC-MS for a bacterial system. Last, analysis identified previously characterized E. coli protein assemblies and condensates, as well as potentially novel associations of prokaryote metabolism with large subcellular bodies. We propose this unbiased method can be used to stimulate or supplement targeted methods for discovery of new cellular bodies in a wide range of cell types.

Indexed as

Chromatography, GelEscherichia coliEscherichia coli ProteinsMass SpectrometryProteomicsCross-Linking ReagentsFormaldehydeCross-Linking ReagentsEscherichia coli ProteinsFormaldehyde

Identifiers

PMID41566810
PMCPMC13106914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.